%20(2).png){kind=logo}
Verily’s ex-chief commercial officer sued the healthtech company for wrongful employment, citing HIPAA violations.
MM+M’s latest eBook explores how pharma brands can embrace AI to engage HCPs more effectively and become trusted partners by delivering relevant and meaningful content dynamically.
The U.S. will impose 100% tariffs on imported branded drugs from Oct. 1, 2025, exempting firms with U.S. projects. Pharma must localize, pursue deals, and manage unclear exemption rules.
Watch a live demo of Ostro’s AI agents transforming how pharma brands engage patients and HCPs—delivering PRC-compliant, dynamic conversations via tailored email and SMS experiences.
A global pharma brand used Ostro Tailor to personalize oncology websites, boosting rep engagement, resource access, and HCP conversions.
The unified digital platform helps providers and patients access clear, compliant, and personalized pharmaceutical information with AI-powered tools.
Pharma is shifting from one-way email and SMS blasts to AI-driven, two-way, compliant conversations that deliver personalized, on-demand engagement for healthcare professionals.
.svg)